Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-08-15

Clinical Trial Update: A Prospective Clinical Trial in Chronic Hepatitis B Patients NAs (Nucleotides or Nucleosides) Experienced (Anchor Study) [Phase 3]

View source ↗

Summary

A Phase 3 prospective trial in chronic hepatitis B patients who have prior exposure to nucleos(t)ide analogs (the anchor study) is sponsored by Tongji Hospital;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Tongji Hospital | Conditions: Hepatitis B, Chronic | Phase 3 | Status: UNKNOWN